| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6156959 | American Journal of Kidney Diseases | 2015 | 6 Pages |
Abstract
Febuxostat slowed the decline in eGFR in CKD stages 3 and 4 compared to placebo.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Dipankar MD, DM, Soumya MD, Rajesh MD, DM, Vishal MD, DM, Arpita MD, DM, Suparna MD, Rajendra MD, DM,